Korea S.E.
18:00:00 2024-05-30 EDT
5-day change
1st Jan Change
5,030
KRW
-0.40%
-2.33%
-12.67%
Dongsung Pharmaceutical Co. Ltd. announced that it expects to receive KRW 3 billion in funding.
February 27, 2012 at 11:00 pm
Dongsung Pharmaceutical Co. Ltd. (KOSE:A002210) announced a private placement of 29th unregistered/unsecured private bonds along with warrants for gross proceeds of KRW 3,000,000,000 on February 28, 2012. The bonds will mature on February 24, 2015 and warrants are exercisable at a price of KRW 2,350 from March 1, 2013 to February 22, 2015.
Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding
23-07-23
CI
Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding
23-07-19
CI
Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback announced on June 23, 2022, has expired.
22-09-22
CI
Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on June 23, 2022.
22-08-24
CI
Dong Sung Bio Pharm.Co.,Ltd. announces an Equity Buyback for 261,780 shares.
22-06-23
CI
Dong Sung Bio Pharm.Co.,Ltd. authorizes a Buyback Plan.
22-06-22
CI
Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback announced on August 20, 2021, has expired.
21-11-18
CI
Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on August 20, 2021.
21-10-07
CI
Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 8.5 billion in funding from a group of investors
21-08-22
CI
Dong Sung Bio Pharm.Co.,Ltd. announces an Equity Buyback for 209,424 shares.
21-08-20
CI
Dong Sung Bio Pharm.Co.,Ltd. authorizes a Buyback Plan.
21-08-19
CI
Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 8.5 billion in funding from a group of investors
21-08-12
CI
Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback announced on March 19, 2020, has expired.
20-06-18
CI
Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on March 19, 2020.
20-04-21
CI
Dong Sung Bio Pharm.Co.,Ltd. announces an Equity Buyback for 233,918 shares.
20-03-19
CI
Dong Sung Bio Pharm.Co.,Ltd. authorizes a Buyback Plan.
20-03-18
CI
Dong Sung Bio Pharm.Co.,Ltd.(KOSE:A002210) added to S&P Global BMI Index
18-09-24
CI
Dongsung Pharmaceutical Co.,Ltd announced that it has received KRW 24 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm and other investors
18-04-15
CI
Dongsung Pharmaceutical Co.,Ltd announced that it expects to receive KRW 24 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm and other investors.
18-04-08
CI
Dongsung Pharmaceutical Co. Ltd. announced that it has received KRW 10 billion in funding from Synergy Partners Co., Ltd., Golden Bridge Asset Management Co., Ltd., Susung Asset Management Co., Ltd., NH Investment & Securities Co., Ltd., Investment Arm
16-07-11
CI
Dongsung Pharmaceutical Co. Ltd. announced that it expects to receive KRW 10 billion in funding from Synergy Partners Co., Ltd., Golden Bridge Asset Management Co., Ltd., Susung Asset Management Co., Ltd., NH Investment & Securities Co., Ltd., Investment Arm
16-07-10
CI
BioGaia AB Signs Exclusive Distribution Agreement with Dongsung Pharmaceutical Co. Ltd
13-05-07
CI
Dongsung Pharmaceutical Co. Ltd. announced that it has received KRW 3 billion in funding.
12-02-28
CI
Dongsung Pharmaceutical Co. Ltd. announced that it expects to receive KRW 3 billion in funding.
12-02-27
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Dongsung Pharmaceutical Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include anti-rheumatic, anti-inflammatory analgesics, anti-inflammatory enzymes, drugs for cardiovascular system, gastrointestinal drugs, antispasmodic agents, respiratory agents, anti-histamine, dermatologicals, antibiotics, antidiarrheals, antifungals, oral hypoglycemic agents, hormones, hypnotics and others. It also produces hair dyes and cosmetics. The Company distributes its products within domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-12.67% 83.17M +15.91% 41.97B +22.40% 22.34B +18.48% 15.25B +16.12% 14B +45.12% 12.06B -9.58% 6.8B -0.05% 6.79B -8.87% 5.73B +14.18% 5.49B
Generic Pharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
DONG SUNG BIO PHARM.CO.,LTD. 
